Related references
Note: Only part of the references are listed.Critical Evaluation of the Scientific Content in Clinical Practice Guidelines
Zaid M. Abdelsattar et al.
CANCER (2015)
Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO)
J. J. Vehreschild et al.
ANNALS OF ONCOLOGY (2014)
Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers
Sudeep J. Karve et al.
BMC HEALTH SERVICES RESEARCH (2014)
Examining and addressing evidence-practice gaps in cancer care: a systematic review
Jamie Bryant et al.
IMPLEMENTATION SCIENCE (2014)
Attitudes Toward and Use of Cancer Management Guidelines in a National Sample of Medical Oncologists and Surgeons
Reshma Jagsi et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy-findings from clinical practice
K. Krzemieniecki et al.
SUPPORTIVE CARE IN CANCER (2014)
Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy
Mi Rim Choi et al.
SUPPORTIVE CARE IN CANCER (2014)
Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry
E. C. Inwald et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Impact of Cancer Supportive Care Pathways Compliance on Emergency Department Visits and Hospitalizations
Eugene D. Kreys et al.
JOURNAL OF ONCOLOGY PRACTICE (2014)
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials
G. H. Lyman et al.
ANNALS OF ONCOLOGY (2013)
Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer
Genevieve M. Boland et al.
CANCER (2013)
Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study
L. Jolis et al.
EUROPEAN JOURNAL OF CANCER CARE (2013)
Critical Evaluation of Oncology Clinical Practice Guidelines
Bradley N. Reames et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
Christopher R. Flowers et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy
Charles L. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Comparison of Pegfilgrastim Prescribing Practice to National Guidelines at a University Hospital Outpatient Oncology Clinic
Geralyn E. Waters et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
A Way Forward on the Medically Appropriate Use of White Cell Growth Factors
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Predicting Individual Risk of Neutropenic Complications in Patients Receiving Cancer Chemotherapy
Gary H. Lyman et al.
CANCER (2011)
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2011)
Use of Colony-Stimulating Factors With Chemotherapy: Opportunities for Cost Savings and Improved Outcomes
Arnold L. Potosky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Personalized Medicine and Cancer Supportive Care: Appropriate Use of Colony-Stimulating Factor Support of Chemotherapy
Nicole M. Kuderer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia
Gary H. Lyman et al.
CANCER (2010)
Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines
C. Falandry et al.
EUROPEAN JOURNAL OF CANCER (2010)
Fever and neutropenia: the early years
Gerald P. Bodey
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
PLOS MEDICINE (2007)
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer
N Hébert-Croteau et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Statistical modeling: The two cultures
L Breiman
STATISTICAL SCIENCE (2001)
Etoposide plus cisplatin with or without the combination of 4′-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer:: A French federation of cancer institutes multicenter phase III randomized study
JL Pujol et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
